Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00754429Phase 4Completed
Phase 4, randomised trial of losartan in hypertension (HTN) (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoints: Middle Cerebral Artery Flow Velocity at 30 weeks and Cerebral Autoregulatory Indices at 30 weeks. Started Jun 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00754429.